PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
NOTICE - Per the recommendation from OGAC that Malawi as an FY2008 Compact Country, submit a mini
-COP (i.e. program area level narratives only), this activity level narrative has not been updated prior to the
submission of the FY09 Full COP. The Malawi country team anticipates updating narratives upon
completion and final approval of the negotiated 5-year Compact between the United States Government
and the Government of Malawi.
Summary
Through sole sourcing, USG Malawi will partner with the National TB Program (NTP) to develop a national
implementation plan based on a new TB/HIV strategy, extend pilot TB/HIV services, monitor trends in
TB/HIV co-infection, and strengthen the monitoring and evaluation (M&E) of TB/HIV activities.
Overall these planned activities are expected to result in
• Improved coordination of National TB/HIV collaborative activities
• Increased HIV testing of TB patients
• Increased screening for TB in HIV service settings (especially CT and ART)
• Improved documentation of integrated TB/HIV services
• Improved monitoring of TB/HIV co-infection
• Effective supervision of decentralized treatment of MDR-TB cases of identified through the national
surveillance system
Background
A well functioning national coordinating body is critical for effective implementation of TB/HIV activities.
Malawi's TB/HIV coordinating body was established in 2003 as a precondition for implementing the first 3-
year TB/HIV development plan. The body functioned well initially but became weaker over time and was
non functional by the end of 2005. With technical support from USG Malawi, in mid 2007, NTP and the
HIV/AIDS Unit initiated consultations with stakeholders to re-establish a national TB/HIV coordination body
and terms of reference revised in line with current priorities. The coordinating body has constituted a task
force to develop a new National TB/HIV strategic plan that replaces an earlier version which expired in
2005. Prioritization of activities for the new plan period has been done with significant technical input from
USG partners and the new strategy will be in place by the end of 2007.
The USG, MSF-Belgium, and other partners already are supporting a number of successful pilot projects
that integrate TB/HIV activities in different settings. For example, Lighthouse uses partial funding from USG
to implement a model pilot TB/HIV project which integrates HIV testing and counseling (CT) and referral to
ART services as a standard package of care for TB patients. Within the same comprehensive care project,
patients on ART are screened for TB using a standard checklist at every visit and referred to a TB clinic if
TB is evident or suspected. Similarly, all HIV positive clients identified at a co-located VCT center are
screened for TB using a standard checklist and referred for TB services if responses meet a set of
predetermined criteria. Similar activities are being implemented in a number of other sites though practical
details vary depending on infrastructure and human resource capacity. If rolled out, these activities
collectively can reduce the burden of TB in HIV patients and the burden of HIV in TB patients.
Malawi has implemented TB/HIV activities since 1999, when NTP started piloting the World Health
Organization (WHO) coordinated Pro-TEST project. Lessons from this project were applied in developing
the country's first 3-year TB/HIV plan whose implementation was driven solely by NTP. Using FY 2008 EP
funds, NTP will build on positive gains made over the past four years by assisting with an update of
Malawi's first TB-HIV strategic plan that expired in 2005. The focus will be to assist the National TB/HIV
coordinating body in: guiding implementation of the new National TB/HIV Strategy, leveraging resources for
core HIV and TB activities to roll out successful pilot programs that integrate CT in TB settings and TB
screening in HIV settings especially CT sites, ART Clinics, and medical wards. Also the TBD partner will
develop a minimum package of TB infection control measures to be implemented in congregate medical
settings. The infection control measures will only be phased in at five high volume ART and TB sites initially.
All planned activities are new and fit within a broader national TB/HIV effort implemented jointly with
Lighthouse and TB Country assistance Program (TBCAP) and non USG supported partners under the
umbrella of a single national TB/HIV coordinating body (Activity ID# 17384; Activity ID#5948). The activities
are linked to HVCT as a primary source of human resources and commodities for HIV testing and HTXS for
cross referral of HIV-positive TB patients, and screening of ART patients for TB.
Activity 1: Support National Coordination of TB/HIV Activities in Malawi
NTP will use FY 2008 EP funds to support national coordination of TB/HIV by providing resources for
quarterly meetings, supervision, and ongoing program monitoring at National, Zonal, and district levels. The
TBCAP project is already providing significant support for these TB/HV activities in two focus districts. To
avoid duplication of efforts and build on the ongoing efforts TBCAP is included in the membership of the
national TB/HIV coordinating body and the planned activities will target districts that are not covered by
TBCAP.
Activity 2: Roll Out Successful Pilot TB/HIV Activities
NTP will use FY 2008 EP funds to support the screening of HIV-infected patients for TB at 36 HIV
registration sites, and promote counseling and testing for TB patients at 47 TB registration sites that do not
currently provide these services. The process will involve training TB officers on routinely offering HIV
testing to TB patients; strengthening referral linkage between TB, ART, and VCT sites; and promoting
initiation of ARV therapy within TB settings where possible. Cotrimoxazole for prophylaxis in HIV positive TB
patients will be dispensed along with TB drugs.
Activity 3: Implement TB Infection in Medical settings
Activity Narrative: In Malawi, TB infection control is not in place in most settings where people are treated for HIV yet many
patients with potentially contagious TB congregate with vulnerable individuals in these sites. TB infection
prevention is not addressed adequately in the national strategy for infection prevention in medical settings.
NTP will use FY 2008 to support development of a national plan for tuberculosis infection control based on
the addendum to WHO guidelines for TB prevention in Health facilities. Specific activities will include
technical meetings to adapt the WHO addendum to Malawi settings, printing, and dissemination of a TB
infection prevention plan, situation analysis, and phased implementation of the plan based on outcome of
situation analysis. The minimum package of TB infection control measures will be phased in at five high
volume ART and TB sites during FY 2008.
Activity 4: Support Supervision and Monitoring of Decentralized Treatment of MDR-TB
Treatment of MDR TB is an effective strategy for reducing risk of TB among people living with HIV.
Currently the exact magnitude of MDR-TB in Malawi is not known because a drug resistance survey has
never been conducted. However, MDR-TB cases have been reported from routine surveillance of smear
positive re-treatment TB cases. Since 2000, the Central Reference Laboratory (CRL) has reported
cumulatively 72 MDR-TB cases of whom only 12 are known to be still alive. Patients with MDR-TB have not
received treatment in the past due to lack of second line anti-TB drugs and lack of capacity at the Central
Reference Laboratory (CRL) to consistently and reliably support monitoring of treatment responses. CRL
has no capacity to conduct drug and sensitivity testing on second line drugs. The current practice in Malawi
is to offer MDR-TB patients Ethambutol and Isoniazid to reduce infectiousness while offering education on
cough hygiene and the importance of restricting contact with other people.
Given the large pool of people living with HIV in Malawi, even few MDR-TB cases constitute a major public
health concern. Malawi has therefore developed guidelines for management of MDR-TB and has procured
a small supply of second line drugs to treat known MDR-TB cases. FY 2008 funds will be used to print and
disseminate guidelines for management of MDR-TB and to consolidate and roll out program of MDR-TB
treatment as a joint effort between NTP and the HIV/AIDS program. While TBCAP will support surveillance
for MDR-TB, strengthen the Central Reference Laboratory, and enhance surveillance for MDR-TB, NTP will
use FY 2008 EP funding to strengthen supervision of a decentralized management plan for MDR-TB.
These activities will complement core TB activities funded by non-EP funds that include training of providers
on management of MDR-TB.
Activity 5: Strengthen Monitoring and Evaluation of TB/HIV Activities
Testing for HIV, Cotrimoxazole prophylactic therapy and referral for ART services are being integrated
increasingly into management protocol for TB in Malawi. Recording and reporting of these services has
been incomplete and inconsistent due to lack of standard tool to capture all the required HIV information. A
revised TB patient master card has been developed and successfully piloted by Lighthouse and other
partners. In addition to TB data this new tool captures information on HIV status from previous testing, HIV
status from testing at TB registratio sites, ARV treatment status, and whether started before initiation of TB
treatment or in the course of TB treatment. The applicant will use FY 2008 to print and disseminate the new
TB Master card and support its introduction at all TB registration and treatment sites. FY 2008 funds will
support joint system of supervision, data collection, and monitoring for NTP and HIV programs using this
new tool as an entry point.
New/Continuing Activity: Continuing Activity
Continuing Activity: 15410
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
15410 15410.08 HHS/Centers for Ministry of Health, 7131 7131.08 National TB $200,000
Disease Control & Malawi - National Program (NTP)
Prevention TB Program
Table 3.3.12: